Different profile of endothelial cell apoptosis in patients with klinefelter's syndrome

Journal of Endocrinological Investigation

Volumn 36, Issue 2, 2013, Pages 84-91

  Condorelli, R A ^a   Calogero, A E ^a   La Vignera, S ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Endothelial cell apoptosis; Hypogonadism; Klinefelter syndrome

Indexed keywords

TESTOSTERONE; UNDECANOIC ACID; VITRONECTIN RECEPTOR;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM CELL; FLOW CYTOMETRY; HORMONE SUBSTITUTION; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; INTERNATIONAL INDEX OF ERECTILE FUNCTION; KLINEFELTER SYNDROME; MALE; MIDDLE AGED; PROTEIN BLOOD LEVEL;

ADULT; APOPTOSIS; ENDOTHELIUM, VASCULAR; ERECTILE DYSFUNCTION; FLOW CYTOMETRY; HORMONE REPLACEMENT THERAPY; HUMANS; KLINEFELTER SYNDROME; MALE; MIDDLE AGED; TESTOSTERONE;

EID: 84876256987     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/8287     Document Type: Article

References (26)

1. Snyder PJ, Matsumoto AM, Martin KA. UpToDate. Causes of primary hypogonadism in males. www.uptodate.com. Updated September 30, 2009.
2. Robinson A, Bender BG, Linden MG, Salbenblatt JA. Sex chromosome aneuploidy: the Denver Prospective Study. Birth Defects Orig Artic Ser 1990, 26: 59-115.
3. Swerdlow AJ, Higgins CD, Schoemaker MJ, Wright AF, Jacobs PA; United Kingdom Clinical Cytogenetics Group. Mortality in patients with Klinefelter syndrome in Britain: a cohort study. J Clin Endocrinol Metab 2005, 90: 6516-22.
4. Corona G, Rastrelli G, Monami M, et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. Eur J Endocrinol 2011, 165: 687-701.
5. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999, 84: 3666-72.
6. Corona G, Petrone L, Paggi F, et al. Sexual dysfunction in subjects with Klinefelter's syndrome. Int J Androl 2010, 33: 574-80.
7. Foresta C, Caretta N, Lana A, et al. Reduced number of circulating endothelial progenitor cells in hypogonadal men. J Clin Endocrinol Metab 2006, 91: 4599-602.
8. Di Mambro A, Ferlin A, De Toni L, Selice R, Caretta N, Foresta C. Endothelial progenitor cells as a new cardiovascular risk factor in Klinefelter's syndrome. Mol Hum Reprod 2010, 16: 411-7.
9. Stefanec T. Endothelial apoptosis: the missing link between atherosclerosis and SLE? Blood 2004, 103: 3608-9.
10. Shabsigh R. Testosterone therapy in erectile dysfunction and hypogonadism. J Sex Med 2005, 2: 785-92.
11. Mirone V, Imbimbo C, Fusco F, Verze P, Creta M, Tajana G. Androgens and morphologic remodeling at penile and cardiovascular levels: a common piece in complicated puzzles? Eur Urol 2009, 56: 309-16.
12. Ling S, Dai A, Williams MR, et al. Testosterone (T) enhances apoptosis- related damage in human vascular endothelial cells. Endocrinology 2002, 143: 1119-25.
13. Mostafa T, Rashed LA, Kotb K. Testosterone and chronic sildenafil/tadalafil anti-apoptotic role in aged diabetic rats. Int J Impot Res 2010, 22: 255-61.
14. Bojesen A, Juul S, Birkebaek NH, Gravholt CH. Morbidity in Klinefelter syndrome: a Danish register study based on hospital discharge diagnoses. J Clin Endocrinol Metab 2006, 91: 1254-60.
15. Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Oral contraceptives, hormone replacement therapy and thrombosis. Thromb Haemost 2001, 86: 112-23.
16. Campbell WA, Price WH. Venous thromboembolic disease in Klinefelter's syndrome. Clin Genet 1981, 19: 275-80.
17. Costa C, Virag R. The endothelial-erectile dysfunction connection: an essential update. J Sex Med 2009, 6: 2390-404.
18. Bombeli T, Schwartz B, Harlan J. Endothelial cells undergoing apoptosis become proadhesive for nonactivated platelets. Blood 1999, 93: 3831-8.
19. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995, 184: 39-51.
20. Shet AS. Characterizing blood microparticles: technical aspects and challenges. Vasc Health Risk Manag 2008, 4: 769-74.
21. Esposito K, Ciotola M, Giugliano F, et al. Phenotypic assessment of endothelial microparticles in diabetic and nondiabetic men with erectile dysfunction. J Sex Med 2008, 5: 1436-42.
22. Conti E, Carrozza C, Capoluongo E, et al. Insulin-like growth factor- 1 as a vascular protective factor. Circulation 2004, 110: 2260-5.
23. Nurden AT. Polymorphisms of human platelet membrane glycoproteins: Structure and clinical significance. Thromb Haemost 1995, 74: 345-51.
24. Panda D, Kundu GC, Lee BI, et al. Potential roles of osteopontin and alphaVbeta3 integrin in the development of coronary artery restenosis after angioplasty. Proc Natl Acad Sci USA 1997, 94: 9308-13.
25. Stouffer GA, Hu Z, Sajid M, et al. Beta3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin- induced proliferation of cultured smooth muscle cells. Circulation 1998, 97: 907-15.
26. Roth GJ. Platelets and blood vessels: the adhesion event. Immunol Today 1992, 13: 100-5.